Recent FDA announcements to modernize
The FDA’s commissioner Scott Gottlieb made several large announcements this week that reflect a continued drive to reduce regulatory burden to industry to foster an environment for innovation and allowing greater speed to market for regulated products. Earlier in the week the Agency announced its intentions to publish a guidance to “modernize” the 510(k) process: “FDA intends to publish a draft guidance, again in early 2018, setting forth factors that the agency may consider when assessing […]